Status: Recruiting
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes (T2D) inadequately controlled on non-insulin glucose-lowering medications.
Participants needed: 264
Trial details
Age: 22-70Biological sex: AllType: InterventionalSponsor: Endogenex, Inc.Updated: Jun 22, 2026Locations: 45
Eligibility criteria
22- 70 years of age, inclusive. [+10]
Diagnosed with type 1 diabetes. [+40]